peptides
CJC-1295 / Ipamorelin 10mg
The CJC-1295/Ipamorelin combination drives a clean, pulsatile growth hormone release studied for lean mass, recovery, and sleep architecture.
Research-observed benefits
- ›Lean mass support
- ›Deeper sleep
- ›Faster recovery
- ›Improved body composition
Findings reported in in-vitro / preclinical research literature. Not therapeutic claims.
Reconstitution helper
Suggested: 2 mL BAC water → 5.00 mg/mL
CAS Number
—
Purity
99%+
Molecular Formula
—
Stock
200 units
Order type
Purchase option
Quantity
Total
$60
For in-vitro research only. Not for human consumption, diagnostic, or therapeutic use. Storage at -20°C recommended for lyophilized peptides.
CJC-1295 / Ipamorelin — Full Research Breakdown
Tailored information for researchers. All content is for in-vitro / preclinical research context only — not medical advice.
Mechanism of Action
CJC-1295 (GHRH analog, ~8-day half-life) + Ipamorelin (selective GHS-R/ghrelin mimetic). Together they produce strong, clean pulsatile GH release without affecting cortisol or prolactin.
How It Helps
Improves body composition, sleep architecture (especially deep slow-wave sleep), and recovery — a popular foundational research stack.
Half-Life
CJC-1295 (no-DAC): ~30 min; Ipamorelin: ~2 hours; functional GH pulse spans hours.
Onset of Effects
Sleep depth often noted in first week; body composition by week 6–8.
Administration
Subcutaneous, before bed (peak overnight GH pulse) and optionally post-workout.
Storage
Lyophilized frozen; reconstituted refrigerated, 21 days.
Reconstitution Guide
10 mg combined + 2 mL BAC → 5 mg/mL.
Precise Dosing Protocols
Standard research
- Dose:
- 100–300 mcg each peptide per dose
- Frequency:
- 1–3× daily SC
- Duration:
- 12-week cycles
Sleep-focused
- Dose:
- 200 mcg combined
- Frequency:
- Nightly pre-sleep
- Duration:
- 8–12 weeks
Stacks Well With
- ›Tesamorelin
- ›Wolverine Stack (recovery)
- ›MOTS-c (metabolic)
Research-Observed Side Effects
- •Head rush at high dose
- •Transient water retention
- •Vivid dreams (sleep dosing)
Translational Cautions
- •Active malignancy in translational models
Cycling Guidance
12 weeks on, 4 weeks off to maintain pituitary responsiveness.
Research Highlights
- ▸Significant increases in slow-wave sleep duration in published studies.
- ▸Improved lean mass and reduced fat mass over 12-week cycles.